Press "esc" to clear
Go to Advanced Search

Showing results

110 of 232
  • Embargo expired:
    6-Jun-2018 5:00 PM EDT

Article ID: 695522

Drug Combination Offers More Effective Care for Patients Suffering Miscarriage, Penn Study Shows

Perelman School of Medicine at the University of Pennsylvania

A combination of the drugs mifepristone and misoprostol can help bring closure to some women and their families suffering from miscarriage, and reduces the need for surgical intervention to complete the painful miscarriage process. Results of a new clinical trial led by researchers at the Perelman School of Medicine at the University of Pennsylvania, show that while the standard drug regimen using misoprostol on its own frequently fails to complete the miscarriage, a combination of misoprostol and the drug mifepristone works much more reliably.

Released:
4-Jun-2018 11:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
michael_migden.jpg
  • Embargo expired:
    4-Jun-2018 2:15 PM EDT

Article ID: 695495

Checkpoint Inhibitor Shrinks Advanced Squamous Cell Skin Cancer

University of Texas M. D. Anderson Cancer Center

Clinical trials show that an immune checkpoint inhibitor shrinks the tumors of nearly half of patients with an incurable, advanced form of a common skin cancer, an international team led by a researcher at The University of Texas MD Anderson Cancer Center reports in the New England Journal of Medicine.

Released:
1-Jun-2018 4:50 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    3-Jun-2018 7:30 AM EDT

Article ID: 695398

Landmark Study Finds More Breast Cancer Patients Can Safely Forgo Chemotherapy

Loyola University Health System

A 21-gene test could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study published in the New England Journal of Medicine. Loyola Medicine oncologist Kathy Albain, MD, is among the main co-authors.

Released:
31-May-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
DiNardo_C.jpg
  • Embargo expired:
    2-Jun-2018 4:00 PM EDT

Article ID: 695393

Study of acute myeloid leukemia patients shows protein inhibitor drug safe and effective with durable remissions

University of Texas M. D. Anderson Cancer Center

Ivosidenib, an experimental drug that inhibits a protein often mutated in several cancers has been shown to be safe, resulting in durable remissions, in a study of acute myeloid leukemia (AML) with relapsed or refractory disease.

Released:
31-May-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    23-May-2018 5:00 PM EDT

Article ID: 694758

In Helping Smokers Quit, Cash is King, E-cigarettes Strike Out

Perelman School of Medicine at the University of Pennsylvania

Free smoking cessation aids, such as nicotine patches and chewing gum, are a staple of many corporate wellness programs aimed at encouraging employees to kick the habit. But, new research shows that merely offering such aids for free does not help employees quit, whereas supplementing them with financial incentives is three times more effective. The study also provides the first large-scale evidence that offering e-cigarettes to known smokers is not effective at helping smokers stay smoke-free.

Released:
21-May-2018 1:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    23-May-2018 5:00 PM EDT

Article ID: 694817

Electronic Health Records Fail Because They are Merely Digital Remakes of Paper Charts

Perelman School of Medicine at the University of Pennsylvania

Writing in a new Perspective published in the New England Journal of Medicine, researchers from Penn Medicine’s Center for Health Care Innovation argue that Electronic Health Records should be restructured from mere digital remakes of their old pen and paper ancestors into platforms that allow doctors to “subscribe” to their patients’ clinical information to receive real-time updates when an action is required, similar to social media feeds and notifications.

Released:
18-May-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    23-May-2018 12:30 PM EDT

Article ID: 694751

Team Approach to Support Families Improves ICU Patient-Centered Care and Lowers Costs

Health Sciences at the University of Pittsburgh

Families of critically ill hospital patients report higher satisfaction with clinician communication and a better perception of patient-centered care when the care team uses a low-cost strategy involving intensive emotional support and frequent meetings.

Released:
17-May-2018 1:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    21-May-2018 2:15 PM EDT

Article ID: 694780

Eczema Drug Effective Against Severe Asthma

Washington University in St. Louis

Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients’ ability to breathe better than standard therapies. Dupilumab, an injectable anti-inflammatory drug, was approved in 2017 by the Food and Drug Administration as a treatment for eczema, a chronic skin disease.

Released:
17-May-2018 4:35 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    20-May-2018 5:15 PM EDT

Article ID: 694756

Infection Blood Test of Limited Value in Reducing Antibiotic Use

Health Sciences at the University of Pittsburgh

Overall antibiotic use was not curbed by giving physicians the results of biomarker tests in patients with suspected lower respiratory tract infections, according to findings from the Procalcitonin Antibiotic Consensus Trial.

Released:
17-May-2018 1:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
UUHC_141216_049.jpg
  • Embargo expired:
    16-May-2018 5:00 PM EDT

Article ID: 694390

The Opioid Epidemic Has Boosted the Number of Organs Available for Transplant

University of Utah Health

The researchers examined 17 years of transplantation records and found no significant change in the recipients’ chance of survival when the organ donation came from victims of drug intoxication. The study publishes online on May 17 in the New England Journal of Medicine.

Released:
11-May-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites

Showing results

110 of 232





Chat now!